Corticotropin-releasing factor ovine (Ovine CRF) |
| Catalog No.GC32940 |
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 79804-71-0
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Corticotropin-releasing factor (ovine) is a preferential CRF1 receptor agonist.
Corticotropin-releasing factor (ovine), a preferential CRF1 receptor agonist, shows almost 200-fold greater affinity for the CRF1 than CRF2 receptor[1].
Corticotropin-releasing factor (ovine) (Ovine CRF: 0.1-2.5 nM) stimulates corticotropin release by pituitaries of Wistar rats and this effect is augmented two- to three fold in the presence of arginine vasopressin (0.09-0.9 mIU/ml) or oxytocin (0.9-90 mIU/ml) [2]. oCRF (10 μg) suppresses 6-h intake of cafeteria diet-fed rats without regard to macronutrient composition. Rather, oCRF most potently suppresses intake of preferred food items[1].
[1]. Eric P. Zorrilla et al. Human Urocortin 2, a Corticotropin-Releasing Factor (CRF)2 Agonist, and Ovine CRF, a CRF1 Agonist, Differentially Alter Feeding and Motor Activity. Journal of Pharmacology and Experimental Therapeutics September 2004, 310 (3) 1027-1034; [2]. Antoni FA et al. Oxytocin as well as vasopressin potentiate ovine CRF in vitro. Peptides. 1983 Jul-Aug;4(4):411-5.
Average Rating: 5 (Based on Reviews and 39 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *